{"id":20189,"date":"2025-03-28T11:10:54","date_gmt":"2025-03-28T10:10:54","guid":{"rendered":"https:\/\/actubusinessangels.com\/?p=20189"},"modified":"2025-03-28T11:10:54","modified_gmt":"2025-03-28T10:10:54","slug":"angels-sante-accompagne-sirius-neosight","status":"publish","type":"post","link":"https:\/\/www.franceangels.org\/en\/article\/angels-sante-accompagne-sirius-neosight\/","title":{"rendered":"Angels Sant\u00e9 accompagne Sirius Neosight"},"content":{"rendered":"\n<p class=\"has-text-align-justify\"><strong><a href=\"https:\/\/sirius-neosight.com\/\" target=\"_blank\" rel=\"noreferrer noopener\">Sirius Neosight<\/a><\/strong>, soci\u00e9t\u00e9 sp\u00e9cialis\u00e9e dans l&#8217;isolement de cellules tumorales circulantes et le d\u00e9veloppement de tests fonctionnels de pr\u00e9diction de la r\u00e9ponse th\u00e9rapeutique en oncologie l\u00e8ve 4,4 millions d&#8217;euros aupr\u00e8s de nombreux acteurs du financement dont le r\u00e9seau <strong><a href=\"https:\/\/www.angelssante.fr\/\" target=\"_blank\" rel=\"noreferrer noopener\">Angels Sant\u00e9<\/a><\/strong>. <\/p>\n\n\n\n<!--more-->\n\n\n\n<p class=\"has-text-align-justify\">Ce financement a \u00e9t\u00e9 r\u00e9alis\u00e9 aupr\u00e8s de <strong><a href=\"https:\/\/www.gocapital.fr\/\" target=\"_blank\" rel=\"noreferrer noopener\">Go Capital<\/a><\/strong> via son fonds d&#8217;amor\u00e7age GOCA3, de <strong><a href=\"https:\/\/demeter-im.com\/\" target=\"_blank\" rel=\"noreferrer noopener\">DEMETER<\/a><\/strong> via le fonds <strong><a href=\"https:\/\/demeter-im.com\/faim\/\" target=\"_blank\" rel=\"noreferrer noopener\">FAIM<\/a><\/strong> (Fonds d&#8217;Amor\u00e7age Industriel M\u00e9tropolitain) Lyon\/Saint-\u00c9tienne, ainsi que d&#8217;Evolem, de Cr\u00e9dit Agricole Cr\u00e9ation, d&#8217;<strong><a href=\"https:\/\/octalfa.eu\/\" target=\"_blank\" rel=\"noreferrer noopener\">Octalfa<\/a><\/strong>, d&#8217;Angels Sant\u00e9, de <strong><a href=\"https:\/\/invest-fm.com\/fr\/better-angle\/\" target=\"_blank\" rel=\"noreferrer noopener\">Better Angle<\/a><\/strong> et de business angels sp\u00e9cialis\u00e9s dans les sciences de la vie. L&#8217;entreprise est \u00e9galement soutenue par un pool bancaire et de subventions de <strong><a href=\"https:\/\/www.bpifrance.fr\/\" target=\"_blank\" rel=\"noreferrer noopener\">Bpifrance<\/a><\/strong>.<\/p>\n\n\n\n<p class=\"has-text-align-justify\">Fond\u00e9e fin 2023, Sirius Neosight est une spin-off du Centre L\u00e9on B\u00e9rard de Lyon et acad\u00e9mique laboratoires : Centre de Recherche de Canc\u00e9rologie de Lyon (CRCL : Universit\u00e9 Claude Bernard Lyon 1, Inserm, Centre L\u00e9on B\u00e9rard, CNRS) et l\u2019Institut de Chimie et Biochimie Mol\u00e9culaires et Supramol\u00e9culaires (ICBMS : Universit\u00e9 Claude Bernard Lyon 1, INSA Lyon, CPE Lyon et CNRS). Elle s&#8217;appuie sur les recherches men\u00e9es par les Pr Arnaud Vigneron et David Gueyrard, tous deux inventeurs de la technologie et cofondateurs de l&#8217;entreprise, aux c\u00f4t\u00e9s d&#8217;Agn\u00e8s Bastid, PDG de Sirius Neosight. <\/p>\n\n\n\n<p class=\"has-text-align-justify\">Les premiers d\u00e9veloppements ont \u00e9t\u00e9 partiellement financ\u00e9s par des programmes de maturation soutenus par la SATT Pulsalys et le CNRS. Sirius Neosight a ensuite re\u00e7u l&#8217;aide French Tech Emergence de Bpifrance et a \u00e9t\u00e9 laur\u00e9at du concours i-Lab 2024. Ces premiers soutiens financiers ont permis le d\u00e9p\u00f4t des premiers brevets li\u00e9s \u00e0 la technologie de mesure de la fluidit\u00e9 membranaire, qui permet l&#8217;isolement universel et hautement pr\u00e9cis de cellules tumorales circulantes \u00e0 partir d&#8217;un simple \u00e9chantillon sanguin, ainsi que la premi\u00e8re preuve de concept de sa plateforme de pr\u00e9diction de l&#8217;efficacit\u00e9 des traitements. <\/p>\n\n\n\n<p class=\"has-text-align-justify\">Avec cette premi\u00e8re lev\u00e9e de fonds, Sirius entend poursuivre ses ambitions en offrant de nouvelles perspectives en oncologie. Au cours des deux prochaines ann\u00e9es, les ressources financi\u00e8res seront consacr\u00e9es au d\u00e9veloppement d\u2019une plateforme de production biologique et de tests de pr\u00e9diction th\u00e9rapeutique permettant de guider pr\u00e9cis\u00e9ment la r\u00e9ponse fonctionnelle des th\u00e9rapies cibl\u00e9es pour chaque patient, \u00e0 partir d\u2019un simple pr\u00e9l\u00e8vement sanguin. <\/p>\n\n\n\n<p class=\"has-text-align-justify\">Un premier d\u00e9monstrateur clinique devrait \u00eatre lanc\u00e9 en 2025, en partenariat avec le Centre L\u00e9on B\u00e9rard de Lyon, et de nouvelles cibles sont \u00e9galement en cours de d\u00e9veloppement pr\u00e9clinique. Le d\u00e9veloppement op\u00e9rationnel et clinique s\u2019\u00e9tendra au-del\u00e0 de la r\u00e9gion Auvergne-Rh\u00f4ne-Alpes d\u00e8s d\u00e9but 2025, avec l\u2019enregistrement strat\u00e9gique d\u2019un second site op\u00e9rationnel dans le Grand-Ouest et la mise en place d\u2019un partenariat \u00e9troit avec l\u2019Institut de Canc\u00e9rologie de l\u2019Ouest (ICO) et la Plateforme Prot\u2019ICO, acteurs cl\u00e9s de la recherche en canc\u00e9rologie.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Sirius Neosight, soci\u00e9t\u00e9 sp\u00e9cialis\u00e9e dans l&#8217;isolement de cellules tumorales circulantes et le d\u00e9veloppement de tests fonctionnels de pr\u00e9diction de la r\u00e9ponse th\u00e9rapeutique en oncologie l\u00e8ve 4,4 millions d&#8217;euros aupr\u00e8s de nombreux acteurs du financement dont le r\u00e9seau Angels Sant\u00e9.<\/p>\n","protected":false},"author":114,"featured_media":20197,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false},"categories":[173,85,86,60,1462],"tags":[147,63,1467,1468,1469,1377,75,1470,76,93],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v19.7.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Angels Sant\u00e9 accompagne Sirius Neosight - France Angels<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.franceangels.org\/article\/angels-sante-accompagne-sirius-neosight\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Angels Sant\u00e9 accompagne Sirius Neosight - France Angels\" \/>\n<meta property=\"og:description\" content=\"Sirius Neosight, soci\u00e9t\u00e9 sp\u00e9cialis\u00e9e dans l&#8217;isolement de cellules tumorales circulantes et le d\u00e9veloppement de tests fonctionnels de pr\u00e9diction de la r\u00e9ponse th\u00e9rapeutique en oncologie l\u00e8ve 4,4 millions d&#8217;euros aupr\u00e8s de nombreux acteurs du financement dont le r\u00e9seau Angels Sant\u00e9.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.franceangels.org\/article\/angels-sante-accompagne-sirius-neosight\/\" \/>\n<meta property=\"og:site_name\" content=\"France Angels\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/facebook.com\/france.angels\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-28T10:10:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.franceangels.org\/wp-content\/uploads\/2025\/03\/visuels-blog-newsletter-1-1-1024x576.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"576\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"France Angels\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@franceangels\" \/>\n<meta name=\"twitter:site\" content=\"@franceangels\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"France Angels\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.franceangels.org\/article\/angels-sante-accompagne-sirius-neosight\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.franceangels.org\/article\/angels-sante-accompagne-sirius-neosight\/\"},\"author\":{\"name\":\"France Angels\",\"@id\":\"https:\/\/www.franceangels.org\/#\/schema\/person\/23bc1670ad5f0f132d0c3610b1ad2b59\"},\"headline\":\"Angels Sant\u00e9 accompagne Sirius Neosight\",\"datePublished\":\"2025-03-28T10:10:54+00:00\",\"dateModified\":\"2025-03-28T10:10:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.franceangels.org\/article\/angels-sante-accompagne-sirius-neosight\/\"},\"wordCount\":502,\"commentCount\":1368,\"publisher\":{\"@id\":\"https:\/\/www.franceangels.org\/#organization\"},\"keywords\":[\"Angels Sant\u00e9\",\"Business Angels\",\"Cr\u00e9dit Agricole Cr\u00e9ation\",\"Demeter\",\"FAIM\",\"Go Capital\",\"Lev\u00e9e de fonds\",\"Octalfa\",\"R\u00e9seaux de Business Angels\",\"Start-up\"],\"articleSection\":[\"2025\",\"Closing\",\"Les entreprises financ\u00e9es\",\"Les r\u00e9seaux de France Angels\",\"Mars 2025\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.franceangels.org\/article\/angels-sante-accompagne-sirius-neosight\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.franceangels.org\/article\/angels-sante-accompagne-sirius-neosight\/\",\"url\":\"https:\/\/www.franceangels.org\/article\/angels-sante-accompagne-sirius-neosight\/\",\"name\":\"Angels Sant\u00e9 accompagne Sirius Neosight - France Angels\",\"isPartOf\":{\"@id\":\"https:\/\/www.franceangels.org\/#website\"},\"datePublished\":\"2025-03-28T10:10:54+00:00\",\"dateModified\":\"2025-03-28T10:10:54+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.franceangels.org\/article\/angels-sante-accompagne-sirius-neosight\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.franceangels.org\/article\/angels-sante-accompagne-sirius-neosight\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.franceangels.org\/article\/angels-sante-accompagne-sirius-neosight\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.franceangels.org\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Angels Sant\u00e9 accompagne Sirius Neosight\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.franceangels.org\/#website\",\"url\":\"https:\/\/www.franceangels.org\/\",\"name\":\"France Angels\",\"description\":\"F\u00e9d\u00e9ration Nationale des Business Angels\",\"publisher\":{\"@id\":\"https:\/\/www.franceangels.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.franceangels.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.franceangels.org\/#organization\",\"name\":\"France Angels\",\"url\":\"https:\/\/www.franceangels.org\/\",\"sameAs\":[\"https:\/\/linkedin.com\/company\/france-angels\",\"https:\/\/www.youtube.com\/channel\/UC5_t1C5xO9AloWjY4o5ob_Q\",\"https:\/\/facebook.com\/france.angels\/\",\"https:\/\/twitter.com\/franceangels\"],\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.franceangels.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.franceangels.org\/wp-content\/uploads\/2022\/04\/Logo-France-Angels.png\",\"contentUrl\":\"https:\/\/www.franceangels.org\/wp-content\/uploads\/2022\/04\/Logo-France-Angels.png\",\"width\":4033,\"height\":1173,\"caption\":\"France Angels\"},\"image\":{\"@id\":\"https:\/\/www.franceangels.org\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.franceangels.org\/#\/schema\/person\/23bc1670ad5f0f132d0c3610b1ad2b59\",\"name\":\"France Angels\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.franceangels.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/7686aa9e66054004e747510168483db8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/7686aa9e66054004e747510168483db8?s=96&d=mm&r=g\",\"caption\":\"France Angels\"},\"url\":\"https:\/\/www.franceangels.org\/en\/article\/author\/france-angels\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Angels Sant\u00e9 accompagne Sirius Neosight - France Angels","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.franceangels.org\/article\/angels-sante-accompagne-sirius-neosight\/","og_locale":"en_US","og_type":"article","og_title":"Angels Sant\u00e9 accompagne Sirius Neosight - France Angels","og_description":"Sirius Neosight, soci\u00e9t\u00e9 sp\u00e9cialis\u00e9e dans l&#8217;isolement de cellules tumorales circulantes et le d\u00e9veloppement de tests fonctionnels de pr\u00e9diction de la r\u00e9ponse th\u00e9rapeutique en oncologie l\u00e8ve 4,4 millions d&#8217;euros aupr\u00e8s de nombreux acteurs du financement dont le r\u00e9seau Angels Sant\u00e9.","og_url":"https:\/\/www.franceangels.org\/article\/angels-sante-accompagne-sirius-neosight\/","og_site_name":"France Angels","article_publisher":"https:\/\/facebook.com\/france.angels\/","article_published_time":"2025-03-28T10:10:54+00:00","og_image":[{"width":1024,"height":576,"url":"https:\/\/www.franceangels.org\/wp-content\/uploads\/2025\/03\/visuels-blog-newsletter-1-1-1024x576.png","type":"image\/png"}],"author":"France Angels","twitter_card":"summary_large_image","twitter_creator":"@franceangels","twitter_site":"@franceangels","twitter_misc":{"Written by":"France Angels","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.franceangels.org\/article\/angels-sante-accompagne-sirius-neosight\/#article","isPartOf":{"@id":"https:\/\/www.franceangels.org\/article\/angels-sante-accompagne-sirius-neosight\/"},"author":{"name":"France Angels","@id":"https:\/\/www.franceangels.org\/#\/schema\/person\/23bc1670ad5f0f132d0c3610b1ad2b59"},"headline":"Angels Sant\u00e9 accompagne Sirius Neosight","datePublished":"2025-03-28T10:10:54+00:00","dateModified":"2025-03-28T10:10:54+00:00","mainEntityOfPage":{"@id":"https:\/\/www.franceangels.org\/article\/angels-sante-accompagne-sirius-neosight\/"},"wordCount":502,"commentCount":1368,"publisher":{"@id":"https:\/\/www.franceangels.org\/#organization"},"keywords":["Angels Sant\u00e9","Business Angels","Cr\u00e9dit Agricole Cr\u00e9ation","Demeter","FAIM","Go Capital","Lev\u00e9e de fonds","Octalfa","R\u00e9seaux de Business Angels","Start-up"],"articleSection":["2025","Closing","Les entreprises financ\u00e9es","Les r\u00e9seaux de France Angels","Mars 2025"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.franceangels.org\/article\/angels-sante-accompagne-sirius-neosight\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.franceangels.org\/article\/angels-sante-accompagne-sirius-neosight\/","url":"https:\/\/www.franceangels.org\/article\/angels-sante-accompagne-sirius-neosight\/","name":"Angels Sant\u00e9 accompagne Sirius Neosight - France Angels","isPartOf":{"@id":"https:\/\/www.franceangels.org\/#website"},"datePublished":"2025-03-28T10:10:54+00:00","dateModified":"2025-03-28T10:10:54+00:00","breadcrumb":{"@id":"https:\/\/www.franceangels.org\/article\/angels-sante-accompagne-sirius-neosight\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.franceangels.org\/article\/angels-sante-accompagne-sirius-neosight\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.franceangels.org\/article\/angels-sante-accompagne-sirius-neosight\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.franceangels.org\/en\/"},{"@type":"ListItem","position":2,"name":"Angels Sant\u00e9 accompagne Sirius Neosight"}]},{"@type":"WebSite","@id":"https:\/\/www.franceangels.org\/#website","url":"https:\/\/www.franceangels.org\/","name":"France Angels","description":"F\u00e9d\u00e9ration Nationale des Business Angels","publisher":{"@id":"https:\/\/www.franceangels.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.franceangels.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.franceangels.org\/#organization","name":"France Angels","url":"https:\/\/www.franceangels.org\/","sameAs":["https:\/\/linkedin.com\/company\/france-angels","https:\/\/www.youtube.com\/channel\/UC5_t1C5xO9AloWjY4o5ob_Q","https:\/\/facebook.com\/france.angels\/","https:\/\/twitter.com\/franceangels"],"logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.franceangels.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.franceangels.org\/wp-content\/uploads\/2022\/04\/Logo-France-Angels.png","contentUrl":"https:\/\/www.franceangels.org\/wp-content\/uploads\/2022\/04\/Logo-France-Angels.png","width":4033,"height":1173,"caption":"France Angels"},"image":{"@id":"https:\/\/www.franceangels.org\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.franceangels.org\/#\/schema\/person\/23bc1670ad5f0f132d0c3610b1ad2b59","name":"France Angels","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.franceangels.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/7686aa9e66054004e747510168483db8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7686aa9e66054004e747510168483db8?s=96&d=mm&r=g","caption":"France Angels"},"url":"https:\/\/www.franceangels.org\/en\/article\/author\/france-angels\/"}]}},"_links":{"self":[{"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/posts\/20189"}],"collection":[{"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/users\/114"}],"replies":[{"embeddable":true,"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/comments?post=20189"}],"version-history":[{"count":0,"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/posts\/20189\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/media\/20197"}],"wp:attachment":[{"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/media?parent=20189"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/categories?post=20189"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/tags?post=20189"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}